The first-ever clinical trial for treatments targeting the Bundibugyo Ebola strain has enrolled its first patient in the Democratic Republic of Congo, the World Health Organization announced Thursday. The PARTNERS trial, launched as the outbreak continues spreading in northeastern DRC, aims to find the first effective therapies for a virus that has already claimed 438 lives among more than 1,400 confirmed cases — with no approved vaccines or treatments...